The frequency of postdural puncture headache in obstetric patients: a prospective study comparing the 24-gauge versus the 22-gauge Sprotte needle

J Clin Anesth. 1994 Jan-Feb;6(1):42-6. doi: 10.1016/0952-8180(94)90117-1.

Abstract

Study objective: To compare the frequency of postdural puncture headache (PDPH) in obstetric patients when using the 24-gauge or the larger 22-gauge Sprotte needle.

Design: Prospective, randomized study.

Setting: Four hospitals.

Patients: 375 ASA physical status I and II cesarean section and postpartum tubal ligation patients.

Interventions: Obstetric patients were randomly assigned to receive spinal anesthesia via a midline dural puncture using the 24-gauge or the 22-gauge Sprotte needle.

Measurements and main results: The rate of PDPH was determined by a postoperative visit by the anesthesiologist as well as questioning patients by telephone 1 week or more after discharge. In the 24-gauge Sprotte needle group (n = 186), 2 mild and 1 moderate PDPHs were reported, for an overall rate of 1.61%. In the 22-gauge Sprotte needle group (n = 189), 2 mild and 1 moderate PDPHs were reported, for an overall rate of 1.59%. All headaches except 1 resolved within 72 hours with conservative treatment. One patient from the 22-gauge Sprotte needle group required an epidural blood patch. There were no failed blocks in either group.

Conclusions: Our results suggest that the 22-gauge Sprotte needle, when compared with the smaller 24-gauge Sprotte needle, can be used in obstetric patients without increasing the frequency of PDPH.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Anesthesia, Obstetrical*
  • Anesthesia, Spinal*
  • Bupivacaine
  • Cesarean Section*
  • Female
  • Fentanyl
  • Headache / etiology*
  • Humans
  • Lidocaine
  • Morphine
  • Needles*
  • Pregnancy
  • Prospective Studies
  • Spinal Puncture / adverse effects*
  • Sterilization, Tubal*

Substances

  • Morphine
  • Lidocaine
  • Fentanyl
  • Bupivacaine